Carmona Richard H

SEC source: 0001213900-26-055395 · ownership.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,645

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2027, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001213900-25-040325 · ownership.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,766

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2026, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001062993-24-014306 · form4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349

Underlying: Common Stock · 349 shares

Expires not disclosed

F1 · derivative.exercise_date: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

F1 · derivative.expiration_date: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

SEC source: 0000950170-24-054825 · ownership.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,909

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2025, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0000950170-23-071961 · ownership.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,369

F1 · shares: The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.

SEC source: 0001062993-23-015296 · form4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 483

Underlying: Common Stock · 483 shares

Expires not disclosed

F1 · derivative.exercise_date: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

F1 · derivative.expiration_date: RSUs granted pursuant to an automatic annual grant under the 2022 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

SEC source: 0000950170-23-027338 · ownership.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2033-06-06

F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 7, 2023.

SEC source: 0001209191-23-028058 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,252

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2023 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2024, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001062993-22-016742 · form4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 606

Underlying: Common Stock · 606 shares

Expires not disclosed

F1 · derivative.exercise_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

F1 · derivative.expiration_date: RSUs granted pursuant to an automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however, receipt of the underlying shares is deferred until the Director leaves the Board.

SEC source: 0000899243-22-021935 · doc4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-08

F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022.

SEC source: 0001209191-22-027827 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,223

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2023, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001225208-22-000180 · doc4.xml · derivative · entry 5

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,388.9075

Underlying: Common Stock · 918.6024 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001225208-22-000180 · doc4.xml · derivative · entry 4

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,470.3051

Underlying: Common Stock · 163.4187 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0000899243-21-042257 · doc4.xml · derivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,300

Underlying: Common Stock · 28,300 shares

Expires 2031-10-27

F5 · derivative.exercise_date: Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.

SEC source: 0000899243-21-042257 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,619

F1 · kind: Pursuant to the Agreement and Plan of Merger, as amended (the "Merger Agreement"), by and among Mountain Crest Acquisition Corp. II ("Issuer"), MCAD Merger Sub Inc. ("Merger Sub") and Better Therapeutics, Inc. ("BTX"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the "Business Combination").

F2 · kind: At the effective time of the Business Combination ("Effective Time"), each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475 (the "Exchange Ratio"), with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc.

F3 · kind: At the Effective Time, each award of BTX restricted stock was converted to an award of restricted Issuer common stock (the "Assumed Award") equal to the product of (i) the number of shares of BTX restricted stock and (ii) the Exchange Ratio. Each Assumed Award will continue to be subject to the terms and conditions set forth in the applicable BTX restricted stock agreement.

F4 · kind: The Assumed Award vested as follows: (i) 50% of the shares subject to the Assumed Award vested in 24 equal monthly installments after December 1, 2017 and (ii) 50% of the shares subject to the Assumed Award vested in 12 equal monthly installments after December 1, 2019, provided the Reporting Person continued to have a service relationship with Issuer on each vesting date. The Assumed Award was granted on August 14, 2020.

F1 · price: Pursuant to the Agreement and Plan of Merger, as amended (the "Merger Agreement"), by and among Mountain Crest Acquisition Corp. II ("Issuer"), MCAD Merger Sub Inc. ("Merger Sub") and Better Therapeutics, Inc. ("BTX"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the "Business Combination").

F2 · price: At the effective time of the Business Combination ("Effective Time"), each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475 (the "Exchange Ratio"), with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc.

F3 · price: At the Effective Time, each award of BTX restricted stock was converted to an award of restricted Issuer common stock (the "Assumed Award") equal to the product of (i) the number of shares of BTX restricted stock and (ii) the Exchange Ratio. Each Assumed Award will continue to be subject to the terms and conditions set forth in the applicable BTX restricted stock agreement.

F4 · price: The Assumed Award vested as follows: (i) 50% of the shares subject to the Assumed Award vested in 24 equal monthly installments after December 1, 2017 and (ii) 50% of the shares subject to the Assumed Award vested in 12 equal monthly installments after December 1, 2019, provided the Reporting Person continued to have a service relationship with Issuer on each vesting date. The Assumed Award was granted on August 14, 2020.

SEC source: 0001062993-21-008508 · form4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 762

Underlying: Common Stock · 762 shares

Expires not disclosed

F1 · derivative.exercise_date: RSUs granted to reporting person upon election to the Board pursuant to a prorated automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however receipt of the underlying stock is deferred until the director leaves the Board.

F1 · derivative.expiration_date: RSUs granted to reporting person upon election to the Board pursuant to a prorated automatic annual grant under the 2013 Stock Plan. This grant vests immediately, however receipt of the underlying stock is deferred until the director leaves the Board.

SEC source: 0001225208-22-000180 · doc4.xml · derivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,306.8864

Underlying: Common Stock · 159.4009 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001415889-21-002729 · form4-06012021_040659.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,162

F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 27, 2022.

SEC source: 0001225208-22-000180 · doc4.xml · derivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,147.4855

Underlying: Common Stock · 139.5487 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001209191-21-031419 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,836

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2022, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001225208-22-000180 · doc4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,007.9368

Underlying: Common Stock · 136.5128 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 5

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,871.424

Underlying: Common Stock · 777.268 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001209191-20-060089 · doc4.xml · nonDerivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,116

SEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 4

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,094.1562

Underlying: Common Stock · 120.124 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001209191-20-060089 · doc4.xml · derivative · entry 4

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,052 shares

Expires 2020-12-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 4,526 shares at an exercise price of $79.58 per share.

F1 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 4,526 shares at an exercise price of $79.58 per share.

F2 · derivative.exercise_date: The SARs were granted on December 19, 2013. 50% vested on December 19, 2013, 25% vested on January 15, 2014 and the remaining 25% vested on April 15, 2014.

SEC source: 0001209191-20-060089 · doc4.xml · nonDerivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,668

SEC source: 0001209191-20-060089 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,168

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-048261 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,116

F1 · price: This transaction was executed in multiple trades at prices ranging from $50.12 to $50.17. The price reported reflects the weighted average sale price of $50.13. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,974.0322

Underlying: Common Stock · 108.2321 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001415889-20-001435 · form4-06022020_040615.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,728

F1 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal installments beginning on May 29, 2021.

SEC source: 0001415889-20-001173 · form4-05132020_010554.xml · derivative · entry 5

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,026 shares

Expires 2021-05-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-001173 · form4-05132020_010554.xml · derivative · entry 4

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,041 shares

Expires 2020-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-001173 · form4-05132020_010554.xml · nonDerivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,621

F1 · price: The transaction was executed in multiple trades at prices ranging from $84.79 to $85.78. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001415889-20-001173 · form4-05132020_010554.xml · nonDerivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,688

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001415889-20-001173 · form4-05132020_010554.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,662

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-028811 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,674

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2021, subject to continued service on the Issuer's Board of Directors through such date.

SEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,865.8001

Underlying: Common Stock · 113.0016 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001069183-20-000039 · wf-form4_158344910668052.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,621

F1 · price: This transaction was executed in multiple trades at prices ranging from $79.15 to $79.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,752.7985

Underlying: Common Stock · 138.9955 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 5

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,613.803

Underlying: Common Stock · 1,013.0902 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 4

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,600.7127

Underlying: Common Stock · 149.1989 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,451.5138

Underlying: Common Stock · 133.8516 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001069183-19-000091 · wf-form4_155960033546815.xml · nonDerivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,108

F2 · shares: Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2019 Stock Incentive Plan. The grant is scheduled to vest in three equal annual installments beginning on May 31, 2020.

SEC source: 0001069183-19-000091 · wf-form4_155960033546815.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,712

F1 · price: The transaction was executed in multiple trades at prices ranging from $68.00 to $68.01. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,317.6622

Underlying: Common Stock · 130.7741 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

SEC source: 0001209191-19-028338 · doc4.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,267

F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2020, subject to continued service on the Issuer's Board of Directors through such date.

F2 · balance_after: Reflects 9,289 additional shares of common stock, after giving effect to the Issuer's 2-for-1 stock split on May 14, 2018.

SEC source: 0001069183-19-000045 · wf-form4_155260540497915.xml · derivative · entry 3

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,810 shares

Expires 2019-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001069183-19-000045 · wf-form4_155260540497915.xml · nonDerivative · entry 2

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,647

F1 · price: The transaction was executed in multiple trades at prices ranging from $47.74 to $47.92. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001069183-19-000045 · wf-form4_155260540497915.xml · nonDerivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 1

Carmona Richard H · CIK 0001389349 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,186.8881

Underlying: Common Stock · 123.7352 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1

F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.